Format

Send to

Choose Destination
See comment in PubMed Commons below
Science. 1992 Nov 27;258(5087):1491-4.

Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy.

Author information

1
Stanford University School of Medicine, Division of Immunology and Rheumatology, CA 94305.

Abstract

Experimental autoimmune encephalomyelitis (EAE), a demyelinating disease of the central nervous system that can be induced in susceptible strains of mice by immunization with myelin basic protein (MBP) or its immunodominant T cell determinants, serves as a model of human multiple sclerosis. Tolerance to MBP in adult mice was induced by intraperitoneal injection of synthetic peptides of immunodominant determinants of MBP and prevented MBP-induced EAE. Furthermore, tolerance-inducing regimens of peptides administered to mice after the disease had begun (10 days after induction with MBP) blocked the progression and decreased the severity of EAE. Peptide-induced tolerance resulted from the induction of anergy in proliferative, antigen-specific T cells.

PMID:
1279812
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center